BioAdvance News

BioAdvance Breaks Life Sciences Investing Record Year in 2022

By WebmasterNovember 9, 2022November 1st, 2024No Comments

BioAdvance Breaks Life Sciences Investing Record Year in 2022

Nearly $5 million invested in eight new promising Mid-Atlantic life sciences companies

Previous PostRelmada Therapeutics Provides Corporate Update and Reports Third Quarter 2022 Financial Results
Next PostAnnovis Bio Announces Third Quarter 2022 Results and Provides Corporate Update